Best peptides, by goal.
Most “best peptide” lists rank by what sells. These rank by what has actually been published, using the same evidence tier as the rest of the site. Sometimes the honest answer for a goal is that nothing here is proven, and the page says so.
The short answer, goal by goal
The honest verdict for each goal, in one line. These are written per goal rather than computed from overall evidence grades, because a compound's grade reflects evidence for its own approved use, which is often not the goal it gets marketed for.
| Goal | The honest answer | Assessed |
|---|---|---|
| weight loss | The approved incretin drugs are in a class of their own, supported by the largest obesity trials ever run. | 13 |
| muscle growth | No compound in this category has demonstrated meaningful muscle growth in healthy adults in controlled human trials. | 15 |
| injury recovery | Strong mechanisms, deep animal literature, and no controlled human evidence that any of it translates. | 8 |
| gut health | The most-studied compound here reached Phase 3 and missed its primary endpoint. | 5 |
| anti-aging | Interesting biology, unfalsifiable timelines, and an evidence base that leans heavily on animal lifespan work and single-group literature. | 11 |
| skin and hair | One approved drug for a rare medical indication, and a set of topical cosmetic ingredients whose efficacy claims mostly come from their own manufacturers. | 7 |
| sleep | Small category, old and unimpressive human data, and a compound whose reputation rests substantially on its name. | 4 |
| cognition | The compound here with the most and best human evidence is also the one whose systematic reviews concluded it probably does not help. | 8 |
| libido and sexual function | One approved drug with real trial evidence, an unapproved analog trading on the same mechanism, and a set of fertility-axis hormones whose approved uses are well evidenced while their popular off-label uses are not. | 6 |
| immune support | A handful of compounds with genuine international clinical use, a larger set that remains preclinical, and a category where the framing of immune support obscures how consequential immune modulation actually is. | 7 |
| energy and mitochondrial health | Real and interesting biology, one compound in genuine clinical development for a defined disease, and a marketing layer that consistently converts biomarker correlation into claimed benefit. | 6 |
| hair loss | Plausible mechanisms, cosmetic-grade evidence, and an approved-treatment landscape that this category is not competitive with. | 3 |
Every goal, in depth
This is the one goal where the honest answer is genuinely impressive, and where the gap between the top of the list and everything else is the widest on the site.
A category with enormous marketing energy behind it and almost no completed human outcome evidence to show for it.
The most popular research peptide category, and the one where personal experience is least able to tell you whether anything worked.
A small category with an unusual feature: one of its compounds actually completed late-stage human trials, and the result was not what the field hoped.
The category with the largest claims, the longest timelines, and a measurement problem that no amount of enthusiasm resolves.
Low stakes, low regulatory bar, and an evidence base largely generated by the people selling the ingredients.
A category with real search demand, a memorable name at the centre of it, and a trial record that almost nobody quotes.
Where the outcomes are subjective, the placebo response is enormous, and the compound with the most trial evidence produced the least encouraging result.
A small category containing a genuinely approved drug and a widely-sold unapproved compound trading on its mechanism.
Real biology, persistent translation difficulty, and a reminder that modulating immunity in either direction has consequences.
A young field built on a real discovery, where the gap between the mitochondrial biology and the marketing is unusually wide.
High search demand, minimal clinical evidence, and a mechanism story doing most of the work.